Novo Nordisk
Predictable time to market in device production with Six Theta®
The overall project execution in Novo Nordisk was challenged by too many and too complex product specifications, bringing Novo Nordisk at risk of being delayed in their production of insulin pens.
Watch video"The decision that it will be mandatory to do robustness in device development has been my best management decision in the past 10-15 years"
Jesper Kløve Former SVP, Research & Developmen, Novo Nordisk
in the insulin pen productionPredictable time to market
by introduction of Six Theta Improvement of people's skillset
by making design simple and robustMajor reduction in production complexity